In spite of the fact that they were not significant at the GWAS level, this observation agreed with the fact that anti-SS-A (Ro52/Ro60) autoantibodies have been described as serological markers for both SS and SLE [38–40]. This evidence concerns the gene TRIM21 and synovial sarcoma.